InsiderTrades

Form 4 for SVV Savers Value Village, Inc.

Accepted 2026-08-07 21:35:44 ET · period of report 2026-08-05 · accession 0001883313-26-000062 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
DMT 2026-08-07 21:35 2026-08-05+ SVV Walsh Mark T. CEO, Dir M - OptEx $2.25 +207.9K 247.4K +527% +$468.2K
DMT 2026-08-07 21:35 2026-08-05+ SVV Walsh Mark T. CEO, Dir S - Sale+OE $11.54 -207.9K 47.4K -81% -$2.40M
DMT 2026-08-07 21:35 2026-08-05+ SVV Walsh Mark T. CEO, Dir M - OptEx $2.25 -207.9K 760.4K -21% -$468.2K

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2026-08-05 M A 7,941 $1.41 55,304 D — —
2 Common Common Stock 2026-08-05 S D 7,941 $11.02 47,363 D — — (F1) The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 17, 2026. (F2) This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $11.00 to $11.09. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
3 Common Common Stock 2026-08-06 M A 50,000 $1.41 97,363 D — —
4 Common Common Stock 2026-08-06 M A 50,000 $3.16 147,363 D — —
5 Common Common Stock 2026-08-07 M A 50,000 $1.41 197,363 D — —
6 Common Common Stock 2026-08-07 M A 50,000 $3.16 247,363 D — —
7 Common Common Stock 2026-08-06 S D 50,000 $10.94 197,363 D — — (F1) The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 17, 2026. (F3) This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $10.3850 to $11.04. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
8 Common Common Stock 2026-08-06 S D 50,000 $10.92 147,363 D — — (F1) The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 17, 2026. (F4) This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $10.50 to $11.04. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
9 Common Common Stock 2026-08-07 S D 13,062 $11.66 134,301 D — — (F1) The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 17, 2026. (F5) This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $11.05 to $12.04. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
10 Common Common Stock 2026-08-07 S D 36,938 $12.38 97,363 D — — (F1) The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 17, 2026. (F6) This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $12.06 to $12.67. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
11 Common Common Stock 2026-08-07 S D 13,036 $11.67 84,327 D — — (F1) The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 17, 2026. (F7) This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $11.05 to $12.05. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
12 Common Common Stock 2026-08-07 S D 36,964 $12.38 47,363 D — — (F1) The sale was made pursuant to a 10b5-1 Plan adopted by the reporting person on March 17, 2026. (F8) This price represents the weighted average price per share of common stock of Savers Value Village, Inc. These Shares were executed at a range of prices from $12.07 to $12.63. The Reporting Person undertakes to provide, upon request by the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer, full information regarding the number of Shares sold at each price.
13 Derivative Stock Options (Right to Purchase) 2026-08-05 M D 7,941 $1.41 732,859 D $1.41 · — to 2029-10-07 7,941 Common Stock (F9) Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. (F10) The October 7, 2019 stock option grant vested in substantially equal annual installments over five years starting October 7, 2020, and was fully vested on October 7, 2024. (F11) The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately.
14 Derivative Stock Options (Right to Purchase) 2026-08-06 M D 50,000 $1.41 682,859 D $1.41 · — to 2029-10-07 50,000 Common Stock (F9) Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. (F10) The October 7, 2019 stock option grant vested in substantially equal annual installments over five years starting October 7, 2020, and was fully vested on October 7, 2024. (F11) The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately.
15 Derivative Stock Options (Right to Purchase) 2026-08-06 M D 50,000 $3.16 810,395 D $3.16 · — to 2030-12-09 50,000 Common Stock (F9) Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. (F12) The December 9, 2020 stock option grant vested in substantially equal annual installments over five years starting December 9, 2021 and was fully vested on December 9, 2025. (F11) The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately.
16 Derivative Stock Options (Right to Purchase) 2026-08-07 M D 50,000 $1.41 632,859 D $1.41 · — to 2029-10-07 50,000 Common Stock (F9) Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. (F10) The October 7, 2019 stock option grant vested in substantially equal annual installments over five years starting October 7, 2020, and was fully vested on October 7, 2024. (F11) The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately.
17 Derivative Stock Options (Right to Purchase) 2026-08-07 M D 50,000 $3.16 760,395 D $3.16 · — to 2030-12-09 50,000 Common Stock (F9) Options previously granted under the Registrant's 2019 Management Incentive Plan. Each option represents the right to receive upon exercise one share of the Registrant's common stock subject to the applicable vesting and settlement conditions. (F12) The December 9, 2020 stock option grant vested in substantially equal annual installments over five years starting December 9, 2021 and was fully vested on December 9, 2025. (F11) The total outstanding excludes the portion of the original option grant that was solely performance-based, which will be reported separately.